Effect of Astragalus Membranaceus on Proliferation,differentiation of Endothelial Progenitor Cells from Peripheral Blood in Patients with Type 2 Diabetes

徐寒松,吴青,谢晓云,孔德明
DOI: https://doi.org/10.3969/j.issn.1000-7369.2011.07.104
2011-01-01
Abstract:Objective:To study the effects of Astragalus membranaceus on the proliferation,differentiation of endothelial progenitor cells(EPCs) from peripheral blood in patients with type 2 diabetes. Methods:Total mononuclear cells were isolated from patients with type 2 diabetes(n=20) and age-matched control subjects(n=20) by Ficoll density gradient centrifugation,and then the cells were plated on fibronectin coated culture dishes. After 7 days of culture,attached cells were stimulated with Astragalus membranaceus in a series of concentrations(0.2,2,20and200mg/ml) for different durations(6,12,24,and 48h) . EPCs were characterized as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. The effect of Astragalus membranaceus on EPCs proliferation,differentiation was measured by MTT assay and flow cytometry. Results:The number and proliferation of EPCs was significantly reduced in patients with type 2 diabetes as compared with that in control subjects(P0.01,P0.05) ,and it was inversely correlated with HbA1c levels and the course of diabetes(P0.01) ;the relative proportion of diabetic EPCs expressing CD14 and CD64 was increased and expressing the endothelial marker von Willebrand factor was reduced as compared with that in control subjects(P0.01) . Astragalus membranaceus could markedly promote the proliferation and the differentiation toward the endothelial cell lineage of EPCs in T2DM in a time-and dose-dependent manner. Conclusion:Astragalus membranaceus could markedly promote the proliferation and the differentiation toward the endothelial cell lineage of EPCs in T2DM.
What problem does this paper attempt to address?